METFORMIN
Clinical trials for METFORMIN explained in plain language.
Never miss a new study
Get alerted when new METFORMIN trials appear
Sign up with your email to follow new studies for METFORMIN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a common diabetes drug help kidneys in sepsis?
Disease control CompletedThis study tested whether metformin, a common diabetes drug, is safe and practical to use for treating acute kidney injury caused by sepsis. Researchers gave low-dose metformin to 80 ICU patients with sepsis and kidney injury, monitoring for side effects and feasibility. The goal…
Matched conditions: METFORMIN
Phase: PHASE2 • Sponsor: Hernando Gomez • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Can diabetes drugs fix Post-Transplant metabolism? new trial investigates
Disease control CompletedThis study looked at whether two diabetes drugs, metformin and empagliflozin, can safely improve metabolic problems (like unhealthy fat buildup and blood sugar issues) in people who have had a kidney transplant. 105 kidney transplant recipients with good kidney function were rand…
Matched conditions: METFORMIN
Phase: NA • Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Common diabetes drug may limit your workout — study tests the theory
Knowledge-focused CompletedThis study looked at whether short-term use of metformin, a common diabetes drug, changes how well healthy young adults can exercise. Fourteen participants took metformin or a placebo and did bike tests to measure endurance and blood lactate levels. The goal was to see if metform…
Matched conditions: METFORMIN
Phase: PHASE4 • Sponsor: University of Virginia • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC